by susuguo | May 18, 2023
By Tomas J. Philipson Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration...
by susuguo | Apr 19, 2023
By Joel Zinberg & Casey B. Mulligan Many politicians, public-health figures, and media pundits continue to insist that the Covid lockdowns were a success and represent a blueprint for future pandemic responses. Illinois governor J. B. Pritzker recently claimed...
by susuguo | Apr 12, 2023
By Tomas J. Philipson Section 11004 of The Inflation Reduction Act allocates $3 billion to the Centers for Medicare & Medicaid Services over the next decade to execute the legislation’s drug-price negotiations. That’s an excessively large amount of funding, far...
